A CLINICAL STUDY OF THE EFFECTS OF ME 1207 ON RESPIRATORY INFECTIONS
ME 1207, a new oral cephem antibiotic, was administered to 29 patients with espiratory infections (pharyngolaryngitis, bronchitis, pneumonia, chronic bronchitis and bronchiectasis in the phase of acute exacerbation) to determine its efficacy and safety profile. Based on the clinical response, result...
Saved in:
| Published in: | CHEMOTHERAPY Vol. 40; no. Supplement2; pp. 724 - 727 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English Japanese |
| Published: |
Japanese Society of Chemotherapy
1992
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | ME 1207, a new oral cephem antibiotic, was administered to 29 patients with espiratory infections (pharyngolaryngitis, bronchitis, pneumonia, chronic bronchitis and bronchiectasis in the phase of acute exacerbation) to determine its efficacy and safety profile. Based on the clinical response, results of examinations and X-ray findings, the drug efficacy was evaluated as “excellent” in 4 patients, “good” in 16, “ fair”in 6 and “poor” in 3, the effectiveness rate being 69%. Neither serious adverse drug reactions nor abnormal laboratory data were observed. The results of this clinical study suggest that ME 1207 is useful in the treatment of respiratory infections. |
|---|---|
| ISSN: | 0009-3165 1884-5894 |
| DOI: | 10.11250/chemotherapy1953.40.Supplement2_724 |